Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
Castor joins experts from United Biosource (UBC) and Datavant to discuss all things real-world evidence, patient-centric technologies, and the role of tokenization in clinical research.
Learn why clinical trial transformation demands a willingness to embrace change and view technology as a facilitator for refined operational methodologies, rather than being confined by technological constraints.
In this webinar, panelists discuss how connecting sources of real world data (RWD) to clinical trial enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1447084050 data]( "Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials")
Digital/Hybrid Trials Deliver Greater ROI Than Traditional TrialsIn this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.
-
![clinical-trials-challenges-GettyImages-1474299453]( "How To Streamline The Complexity Of Clinical Trials")
How To Streamline The Complexity Of Clinical TrialsStreamlining intricate end-to-end processes ensures that data moves with speed and security, converting the current landscape of logistical bottlenecks into a transparent, high-efficiency engine.
-
![GettyImages-1403114912 oncology patient]( "Simply Digital: Trial Technologies Help Reduce Oncology's Burden")
Simply Digital: Trial Technologies Help Reduce Oncology's BurdenOncology trials are notorious for presenting participants and sites with many challenges. With the FDA having put its support behind digital tools, learn how they make oncology trials easier for everyone.
-
![GettyImages-1355166705 ePRO]( "3 Steps To Improve Site Acceptance Of ePRO In Medical Device Trials")
3 Steps To Improve Site Acceptance Of ePRO In Medical Device TrialsDiscover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.
-
![technology]( "Three Benefits Of Centralizing Global Content For eCOA Migration")
Three Benefits Of Centralizing Global Content For eCOA MigrationNow, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.
-
![GettyImages-1451854647 nurse data]( "2024: The Year Of EHR eSource In Clinical Trials")
2024: The Year Of EHR eSource In Clinical TrialsDiscover the power of EHR eSource in 2024—unlock 10 compelling reasons to elevate your approach and enhance clinical research outcomes.
-
![GettyImages-1291203185 consent]( "Why eConsent Makes Such A Difference In Patient Adherence And Engagement")
Why eConsent Makes Such A Difference In Patient Adherence And EngagementExplore how consent is a critical step that can greatly influence patient enrollment, adherence and retention in the trial.
-
![Clinical Trial concept]( "Build Versus Buy: What's The Best Tech Tool For Study Activation?")
Build Versus Buy: What's The Best Tech Tool For Study Activation?In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.
-
![Data time clock GettyImages-454148967]( "Why Now Is The Right Time To Adopt eConsent")
Why Now Is The Right Time To Adopt eConsentAs much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.
-
![wearables-GettyImages-2162402934]( "How AI Activates The Full Potential Of Wearables In Clinical Research")
How AI Activates The Full Potential Of Wearables In Clinical ResearchWearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders